Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1194)
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
271
Price
$765.39
Total Value
$207.42K
Shares Held After
51,214
% of Holdings
0.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
219
Price
$764.40
Total Value
$167.40K
Shares Held After
51,485
% of Holdings
0.4%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
25
Price
$763.76
Total Value
$19.09K
Shares Held After
51,704
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
55
Price
$762.57
Total Value
$41.94K
Shares Held After
51,729
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
27
Price
$761.36
Total Value
$20.56K
Shares Held After
51,784
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
74
Price
$760.65
Total Value
$56.29K
Shares Held After
51,811
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
14
Price
$759.96
Total Value
$10.64K
Shares Held After
51,885
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
24
Price
$758.16
Total Value
$18.20K
Shares Held After
51,899
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
16
Price
$757.68
Total Value
$12.12K
Shares Held After
51,923
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
35
Price
$755.91
Total Value
$26.46K
Shares Held After
51,939
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
MURPHY ANDREW J — Co-Chief Scientific Officer
Shares
6
Price
$753.76
Total Value
$4.52K
Shares Held After
51,974
% of Holdings
0.0%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
10,000
Price
$8.46
Total Value
$84.57K
Shares Held After
1,037,000
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$546.00
Total Value
$21.84K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$545.48
Total Value
$261.83K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$544.35
Total Value
$261.29K
Shares Held After
324,963
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$543.15
Total Value
$217.26K
Shares Held After
325,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
883
Price
$542.07
Total Value
$478.64K
Shares Held After
325,843
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,930
Price
$541.20
Total Value
$1.04M
Shares Held After
326,726
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,002
Price
$540.23
Total Value
$1.08M
Shares Held After
328,656
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
525
Price
$539.09
Total Value
$283.02K
Shares Held After
330,658
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,127
Price
$538.00
Total Value
$606.33K
Shares Held After
331,183
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
633
Price
$537.19
Total Value
$340.04K
Shares Held After
332,310
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$535.89
Total Value
$214.36K
Shares Held After
332,943
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$534.63
Total Value
$128.31K
Shares Held After
333,343
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$532.48
Total Value
$21.30K
Shares Held After
333,583
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$531.19
Total Value
$63.74K
Shares Held After
333,623
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$530.09
Total Value
$84.81K
Shares Held After
333,743
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$526.07
Total Value
$21.04K
Shares Held After
333,903
% of Holdings
0.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,021
Price
$1.33
Total Value
$10.67K
Shares Held After
954,509
% of Holdings
0.8%
Hims&Hers Health, Inc. (HIMS)
Boughton Soleil — Chief Legal Officer
Shares
3,461
Price
$29.06
Total Value
$100.58K
Shares Held After
297,348
% of Holdings
1.2%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
4,098
Price
$49.26
Total Value
$201.87K
Shares Held After
259,736
% of Holdings
1.6%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
1,040
Price
$49.26
Total Value
$51.23K
Shares Held After
95,857
% of Holdings
1.1%
Guardant Health, Inc. (GH)
Azar Alex M II — Director
Shares
69
Price
$159.89
Total Value
$11.03K
Shares Held After
893
% of Holdings
7.2%
CIRCLE8 GROUP INC (CIRC)
Franke Guus Paul Wilhelm — Director
Shares
179,457
Price
$0.38
Total Value
$68.19K
Shares Held After
11,387,928
% of Holdings
1.6%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
4,000
Price
$0.70
Total Value
$2.80K
Shares Held After
10,515,331
% of Holdings
0.0%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
4,000
Price
$0.70
Total Value
$2.80K
Shares Held After
10,511,331
% of Holdings
0.0%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
9,000
Price
$0.68
Total Value
$6.12K
Shares Held After
10,507,331
% of Holdings
0.1%
QTREX Quantum Ltd. (QTEX)
Ben-Noon Dagi Shahar — Director
Shares
14,093
Price
$1.49
Total Value
$21.00K
Shares Held After
14,093
% of Holdings
100.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,881
Price
$25.50
Total Value
$302.97K
Shares Held After
377,802
% of Holdings
3.0%
ANI PHARMACEUTICALS INC (ANIP)
Cook Meredith — SR. VP, GENERAL COUNSEL&SEC.
Shares
500
Price
$73.59
Total Value
$36.80K
Shares Held After
73,424
% of Holdings
0.7%
Beyond Air, Inc. (XAIR)
Lin Yi-Chien — 10% Owner
Shares
2,607
Price
$2.21
Total Value
$5.76K
Shares Held After
148,000
% of Holdings
1.8%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
4,000
Price
$7.18
Total Value
$28.73K
Shares Held After
541,493
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$551.49
Total Value
$44.12K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$550.59
Total Value
$88.09K
Shares Held After
324,523
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
502
Price
$549.47
Total Value
$275.83K
Shares Held After
324,683
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
698
Price
$548.49
Total Value
$382.84K
Shares Held After
325,185
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
630
Price
$547.47
Total Value
$344.91K
Shares Held After
325,883
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,452
Price
$546.46
Total Value
$793.46K
Shares Held After
326,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,507
Price
$545.52
Total Value
$822.10K
Shares Held After
327,965
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,492
Price
$544.56
Total Value
$812.48K
Shares Held After
329,472
% of Holdings
0.5%
1194 transactions